Regeneron appeal on inequitable conduct rejected

02-01-2018

The US Court of Appeals for the Federal Circuit has rejected Regeneron’s request for a panel rehearing and rehearing en banc in a case centring on inequitable conduct.


US Court of Appeals for the Federal Circuit, Regeneron, patent, inequitable conduct, biotech, Merus, genetics

LSIPR